Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptide deformylase (PDF) is a metalloenzyme that catalyzes the removal of the formyl group from the N-terminus of nascent polypeptide chains in bacteria, mitochondria, and chloroplasts. It is essential for protein maturation and bacterial viability, making it an attractive target for antibacterial drug development. Inhibitors like actinonin bind to its active site.
Peptide deformylase inhibitors bind to the enzyme's active site, preventing the removal of the formyl group from nascent polypeptide chains, leading to accumulation of non-functional proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptide Deformylase (PDF).